MYEOV is involved in the pathogenesis of a variety of cancers, including multiple myeloma, neuroblastoma, esophageal cancer, breast cancer, lung cancer, gastric cancer, and colorectal cancer (5). This evidence concerns the gene MYEOV and plasma cell myeloma.